These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 23525579)

  • 1. The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma.
    Pan JJ; Ge YS; Xu GL; Jia WD; Liu WF; Li JS; Liu WB
    J Cancer Res Clin Oncol; 2013 Jun; 139(6):1043-54. PubMed ID: 23525579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of Golgi phosphoprotein-3 is associated with poor survival in patients with hepatocellular carcinoma.
    Hu GS; Li YQ; Yang YM; Shi W; Liao AJ; Yao YH; Zeng B; Yuan J
    Tumour Biol; 2014 Sep; 35(9):8625-32. PubMed ID: 24867097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of Chitinase 3-like 1 and microvessel density predicts metastasis and poor prognosis in clear cell renal cell carcinoma.
    Zhang JP; Yuan HX; Kong WT; Liu Y; Lin ZM; Wangs WP; Guo JM
    Tumour Biol; 2014 Dec; 35(12):12131-7. PubMed ID: 25142236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YKL-40 expression in human hepatocellular carcinoma: a potential biomarker?
    Xiao XQ; Hassanein T; Li QF; Liu W; Zheng YH; Chen J
    Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):605-10. PubMed ID: 22146624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma.
    Wang CH; Li M; Liu LL; Zhou RY; Fu J; Zhang CZ; Yun JP
    Oncotarget; 2015 Dec; 6(39):42118-29. PubMed ID: 26517349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma.
    Chiang YC; Lin HW; Chang CF; Chang MC; Fu CF; Chen TC; Hsieh SF; Chen CA; Cheng WF
    Oncotarget; 2015 Nov; 6(37):39740-55. PubMed ID: 26452028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma.
    Zhang G; Liu T; Wang Z
    J Invest Surg; 2012 Apr; 25(2):93-9. PubMed ID: 21942217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of NEDD9 in hepatocellular carcinoma and its clinical significance.
    Lu P; Wang ZP; Dang Z; Zheng ZG; Li X; Zhou L; Ding R; Yue SQ; Dou KF
    Oncol Rep; 2015 May; 33(5):2375-83. PubMed ID: 25812772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and prognostic value of Polo-like kinase 1, E-cadherin in the patients with hepatocellular carcinoma].
    Chen XJ; Wu LM; Xu XB; Feng XW; Xie HY; Zhang M; Shen Y; Wang WL; Liang TB; Zheng SS
    Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1354-8. PubMed ID: 18241575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryonic morphogen nodal is associated with progression and poor prognosis of hepatocellular carcinoma.
    Chen J; Liu WB; Jia WD; Xu GL; Ma JL; Ren Y; Chen H; Sun SN; Huang M; Li JS
    PLoS One; 2014; 9(1):e85840. PubMed ID: 24465741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
    Xu Q; Cai W; Zhang M; Liu Q; Liu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population.
    Wu S; Chen X; Hu C; Wang J; Shen Y; Zhong Z
    Med Sci Monit; 2017 Dec; 23():5705-5713. PubMed ID: 29192136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
    Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
    World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cytoskeleton regulatory protein Mena in human hepatocellular carcinoma and its prognostic significance.
    Hu K; Wang J; Yao Z; Liu B; Lin Y; Liu L; Xu L
    Med Oncol; 2014 May; 31(5):939. PubMed ID: 24683008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance.
    Ma HX; Shu QH; Pan JJ; Liu D; Xu GL; Li JS; Ma JL; Jia WD; Yv JH; Ge YS
    Tumour Biol; 2015 Jun; 36(6):4235-41. PubMed ID: 25592379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.